GENE ONLINE|News &
Opinion
Blog

Heart Disease
Study Links Cigars, Pipes, and Smokeless Tobacco to Increased Heart Disease Risk
2025-03-19
Protect Animal Health and Rejuvenate Bio Partner to Tackle Canine Heart Disease
2024-12-11
Alnylam Pharma Shares Dip Despite Positive Phase 3 HELIOS-B Heart Disease Results
2024-09-04
‘Heart Attack on a Chip’ Sheds Light on Personalized Drugs Trials
2022-12-14
Bristol Myers Squibb’ sNDA for Rare Heart Disease Treatment Accepted by the FDA
2022-10-21
Potential Novel Anti-thrombotic Treatment by Ionis Pharmaceuticals
2022-07-28
Cytokinetics Poised to Begin Phase 3 after its HCM Drug Registers Encouraging Data
2021-07-21
Verve Makes Successful Wall Street Debut on Back of its Promising Base Editor
2021-06-20
With $41.9 Million from Oversubscribed Financing Round, XyloCor Sets Sights on Gene Therapy for Heart Disease
2021-03-23
Tenaya Raises $106 Million Series C Round To Fight Heart Disease
2021-03-04
Verve Raises $94M in Series B, Aims to Disrupt Cardiology Market with ‘Once-and-Done’ Gene Editing Therapies
2021-01-21
Why is Bristol Myers Squibb Investing $13.1 Billion in MyoKardia?
2020-10-06
Encouraging Performance of Cardiovascular Drug Vindicates Novartis’ $9.7 Billion Buyout Deal
2020-09-06
Verve Therapeutic’s One Time Base Editing Treatment Cuts Down Cholesterol Levels in Blood
2020-06-30
Weekly in Asia |Nov
2019-11-12
LATEST
3D Printing Technology Enhances Patient Education Through Physical Models in Healthcare
2026-01-24
Study Explores Youth Perspectives on Integrating Physical Activity into Substance Use Treatment Programs
2026-01-24
Study Finds Positive Social Feedback Improves Performance and Reduces Stress Levels
2026-01-24
Study Highlights Role of Protein Kinase Variants in Disease and Therapy Development
2026-01-24
HDAC6 Identified as Key Driver of Metastasis and Immunosuppression in Small Cell Lung Cancer Study
2026-01-24
Researchers Develop Antimicrobial Nanomaterials by Functionalizing Graphene Oxide with Metalloporphyrins
2026-01-24
Study Explores Safety and Gut Microbiota Effects of Fulvic Acid Formulations Through In Vitro and Animal Models
2026-01-24
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
Scroll to Top